Targeted Anticancer Therapies Congress becomes an annual ESMO Event

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

European Society For Medical Oncology said it will take over the organization of the Targeted Anticancer Therapies Congress, with the aim of expanding its educational offer and ensure that professionals are kept up-to-date with the latest drug developments to improve outcomes for cancer patients.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login